Safety Alerts & Recalls
Search all Safety Alerts & Recalls
Recall of selected 300mg tablets
GlaxoSmithKline Inc and Biovail Corp have initiated a recall of selected bottles of 300mg WELLBUTRIN XL tablets. These tablets may contain foreign material embedded in the tablets. The recall applies to: WELLBUTRIN XL 300mg tablets Lot: P08A011, Exp May-09
Recall of patches in the United States and Europe
UCB announced today that it will be recalling NEUPRO in the United States and certain batches in Europe. NEUPRO is used for the treatment of Parkinson's disease and is distributed by Schwarz Pharma, a company of UCB Group. UCB has announced this recall because of reduced effectiveness of some of the patches, and NOT because of contamination or safety issues. As a result of this recall, however, NEUPRO will be out-of-stock in the United States from late April 2008. In the European Union and most other regions NEUPRO supply should still be sufficient.